AI Matrx Logo

Clinical research lab

Ostrander Ridge Clinical Research · Clinical research lab · Cincinnati, OH

Dr. Hana Petrov coordinates a phase II trial at Ostrander Ridge Clinical Research in Cincinnati, and she uses this to keep every subject's visits, consent versions and protocol deviations audit-ready, with a checklist for each step the monitor will ask about.

HealthcareComplianceChecklists5 tables · 6 views · 1 form · 2 dimension sets · 2 checklists · 1 document · 1 notification · 1 stage rule set · 1 agent
Use this template

Subject board

Subjects
Screening4
LCR-1156UTMay 6, 1973
LCR-1158KZAug 17, 1959
LCR-1165VMJan 26, 1965
LCR-1170SANov 14, 1969
Screen failed3
LCR-1173ZDJun 2, 1953
LCR-1182QEApr 19, 1976
LCR-1188XRDec 30, 1957
Enrolled5
LCR-1126PKMar 8, 1964
LCR-1131WLDec 15, 1970
LCR-1139ICJul 29, 1956
LCR-1142GRFeb 21, 1967
LCR-1146JBOct 11, 1962
In follow-up6
LCR-1095EJAug 5, 1963
LCR-1099HMMay 19, 1955
LCR-1102NGOct 27, 1968
LCR-1109FQJan 12, 1960
LCR-1118YSApr 4, 1971
1 more
Completed5
LCR-1047MOApr 22, 1961
LCR-1051DKNov 3, 1957
LCR-1060RPJul 18, 1969
LCR-1063LHFeb 27, 1954
LCR-1069TSSep 9, 1972
Withdrawn3
LCR-1077ANJun 14, 1966
LCR-1079CVDec 1, 1959
LCR-1084BWMar 30, 1974

Tables

Subjects

26 sample rows · 16 columns

Every person screened or enrolled in the trial: where they stand, which consent they signed and what is owed to them.

Subject numberInitialsDate of birthContact phoneContact emailStatusScreened
LCR-1047MOApr 22, 1961(513) 555-0102mo307.participant@ostranderparticipants.netCompletedAug 31, 2025
LCR-1051DKNov 3, 1957(513) 555-0104dk314.participant@ostranderparticipants.netCompletedSep 8, 2025
LCR-1060RPJul 18, 1969(513) 555-0106rp321.participant@ostranderparticipants.netCompletedSep 28, 2025
LCR-1063LHFeb 27, 1954(513) 555-0108lh328.participant@ostranderparticipants.netCompletedOct 25, 2025
LCR-1069TSSep 9, 1972(513) 555-0110ts335.participant@ostranderparticipants.netCompletedNov 7, 2025
LCR-1077ANJun 14, 1966(513) 555-0112an342.participant@ostranderparticipants.netWithdrawnNov 27, 2025
LCR-1079CVDec 1, 1959(513) 555-0114cv349.participant@ostranderparticipants.netWithdrawnJan 28, 2026
LCR-1084BWMar 30, 1974(513) 555-0116bw356.participant@ostranderparticipants.netWithdrawnMar 14, 2026
LCR-1095EJAug 5, 1963(513) 555-0118ej363.participant@ostranderparticipants.netIn follow-upJun 1, 2026
LCR-1099HMMay 19, 1955(513) 555-0120hm370.participant@ostranderparticipants.netIn follow-upJun 7, 2026
LCR-1102NGOct 27, 1968(513) 555-0122ng377.participant@ostranderparticipants.netIn follow-upJun 13, 2026
LCR-1109FQJan 12, 1960(513) 555-0124fq384.participant@ostranderparticipants.netIn follow-upJun 19, 2026

14 more rows

Visits

49 sample rows · 9 columns

Each study visit: which subject, what kind, when it was booked, whether it happened and the stipend that follows.

VisitVisit numberSubjectVisit typeStatusScheduled forCompleted on
LCR-1146 BaselineV-2137LCR-1146BaselineCompletedSep 21, 2026Sep 21, 2026
LCR-1156 ScreeningV-2139LCR-1156ScreeningCompletedSep 23, 2026Sep 23, 2026
LCR-1109 End of treatmentV-2123LCR-1109End of treatmentCompletedSep 25, 2026Sep 25, 2026
LCR-1131 Week 4V-2131LCR-1131Week 4CompletedSep 25, 2026Sep 25, 2026
LCR-1158 ScreeningV-2141LCR-1158ScreeningCompletedSep 26, 2026Sep 26, 2026
LCR-1142 Week 2V-2135LCR-1142Week 2CompletedSep 28, 2026Sep 28, 2026
LCR-1165 ScreeningV-2143LCR-1165ScreeningCompletedSep 29, 2026Sep 29, 2026
LCR-1118 End of treatmentV-2125LCR-1118End of treatmentCompletedSep 30, 2026Sep 30, 2026
LCR-1170 ScreeningV-2145LCR-1170ScreeningCompletedOct 2, 2026Oct 2, 2026
LCR-1139 Week 4V-2133LCR-1139Week 4CompletedOct 3, 2026Oct 3, 2026
LCR-1120 End of treatmentV-2127LCR-1120End of treatmentCompletedOct 4, 2026Oct 4, 2026

Consent versions

3 sample rows · 5 columns

Each approved version of the consent form, when the review board approved it and when it took effect.

Consent formBoard approvedIn effect fromStatus
Consent form v3.0Jul 2, 2026Jul 22, 2026Current
Consent form v2.0Jan 28, 2026Feb 17, 2026Superseded
Consent form v1.0Jul 22, 2025Aug 11, 2025Superseded

Protocol deviations

14 sample rows · 9 columns

Every departure from the protocol, how serious it is, and whether the review board has been told.

DeviationDeviation numberSubjectCategorySeverityFound onReported on
LCR-1131: visit outside windowPD-108LCR-1131Visit outside windowMinorSep 17, 2026—
LCR-1139: dosingPD-109LCR-1139DosingMinorSep 23, 2026—
LCR-1102: missed procedurePD-110LCR-1102Missed procedureMinorSep 26, 2026—
LCR-1146: consentPD-111LCR-1146ConsentMinorSep 30, 2026—
LCR-1142: eligibilityPD-113LCR-1142EligibilityMajorOct 2, 2026—

Forms and booking

Report a protocol deviation

Form
Report a protocol deviationThe form anyone on the study team uses the day they spot a departure from the protocol.
In a few words, what happened? *
Which subject was it for? *
What kind of deviation is it? *Visit outside windowMissed procedureDosingConsentEligibility
How serious is it? *MinorMajorMajor means it could affect safety or the data.
When did you find it?
Describe what happened.
File the deviation

Also included

  • Deviation reportDocumentThe one-page report the investigator signs for every deviation.
  • Enrollment readinessChecklist
  • Deviation closeoutChecklist
  • Subject stagesStage rules
  • Visit coming upNotificationReminds the coordinator two days before a subject's visit.

Related templates